Talis Biomedical Corporation Depreciation
Talis Biomedical Corporation reported Depreciation of $6.60 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2023-03-22
- Talis Biomedical Corporation depreciation for the quarter ending 2022-12-31 was $3.30M.
- Talis Biomedical Corporation depreciation for the quarter ending 2022-09-30 was $3.30M.
- Talis Biomedical Corporation depreciation for fiscal 2022 was $6.60M, a 312.50% increase from fiscal 2021.
- Talis Biomedical Corporation depreciation for fiscal 2021 was $1.60M, a 100.00% increase from fiscal 2020.
- Talis Biomedical Corporation depreciation for fiscal 2020 was $800.00K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2022-12-31 | $3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $6.60M derived: sum of 2 quarters · filed 2023-03-22 | $6.60M 10-K · filed 2023-03-22 | |
| 2022-09-30 | $3.30M 10-Q · filed 2022-11-03 | $3.30M 10-Q · filed 2022-11-03 | ||
| 2021-12-31 | $1.60M 10-K · filed 2022-03-15 | |||
| 2020-12-31 | $800.00K 10-K · filed 2022-03-15 |